Alnylam (ALNY) Shares Drop Amid CMS 340B Reimbursement Rule Conc
Alnylam (ALNY) Shares Drop Amid CMS 340B Reimbursement Rule Conc GuruFocus
Covered in this story
What has happened since
- Alnylam Pharmaceuticals is down 4.7% since this was published.
- CMS Energy is up 1.4% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ALNY yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Alnylam Pharmaceuticals →Dalsna Finance is currently tracking 48 stories mentioning Alnylam Pharmaceuticals, the earliest published 16 May 2017.
Summary aggregated from GuruFocus's public RSS feed. The full reporting belongs to GuruFocus — please read it on their site.